Mechanical thrombectomy after acute ischemic stroke in patients with left ventricular assist devices: A nationwide analysis

Abstract

Introduction:

Left ventricular assist devices (LVADs) are an established, durable, and life-saving treatment option for patients with advanced heart failure. However, large vessel occlusions (LVOs) remain one of its most devastating embolic complications. Mechanical thrombectomy (MT) is safe and effective in the management of LVOs in the general population, but LVO trials largely excluded patients on mechanical circulatory support, and large-scale analyses of outcomes following these interventions in the LVAD population are lacking.

Methods:

Using the National Inpatient Sample, we identified all adult patients hospitalized with acute ischemic stroke (AIS) from 2005 to 2018. Regression models adjusting for patient demographics, hospital factors, and clinical severity were used to compare outcomes following MT in patients with and without LVAD. Subgroup analyses were also performed in LVAD patients experiencing stroke in the post-operative setting and stroke in the setting of pre-existing devices.

Results:

Of the 1,633,234 AIS hospitalizations identified, 794 occurred in patients with LVADs. Around 61% were post-operative. Post-stroke in-hospital mortality was higher among patients with LVADs (23.3% vs 7.23%, P < 0.001). Among those receiving MT, mortality was also higher in the LVAD population (31.0% vs 14.1%, P = 0.009), though this was largely driven by the post-operative LVAD subgroup. In multivariable analysis, only post-operative LVAD patients experienced greater odds of in-hospital death after MT (adjusted odds ratio (aOR): 8.66, confidence interval (CI):1.46–51.3); patients with pre-existing LVADs demonstrated no difference in post-MT mortality (aOR: 1.06; 95% CI: 0.29–3.91) or in odds of discharge home after MT (aOR 0.63, CI: 0.17–2.32).

Conclusion:

Our data suggest MT is not a futile treatment approach in patients with pre-existing LVADs and may result in similar rates of good outcomes. Additional research is needed to evaluate the long-term benefits of endovascular therapy after stroke in patients on LVAD support.

Keywords

Mechanical thrombectomy left ventricular assist device ischemic stroke endovascular therapy mortality TPA

Get full access to this article

View all access options for this article.

References

Colombo

Mehra

Goldstein

, et al Comprehensive analysis of stroke in the long-term cohort of the MOMENTUM 3 study. Circulation 2019; 139: 155–168.

Beckman

Cheng

, et al Comparison of neurologic event rates among HeartMate II, HeartMate 3, and HVAD. ASAIO J 2020; 66: 620–624.

Virani

Alonso

Aparicio

, et al Heart disease and stroke statistics-2021 update: a report from the American Heart Association. Circulation 2021; 143: e254–e743.

Rice

Cho

Zhang

, et al The management of acute ischemic strokes and the prevalence of large vessel occlusion in left ventricular assist device. Cerebrovasc Dis 2018; 46: 213–217.

Rettenmaier

Garg

Limaye

, et al Management of ischemic stroke following left ventricular assist device. J Stroke Cerebrovasc Dis 2020; 29: 105384.

Smith

Lev

English

, et al Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke 2009; 40: 3834–3840.

Ryu

Ishikawa

Yamaguchi

, et al Long-term outcomes following thrombectomy for acute ischemic stroke in patients with a left ventricular assist device: a case series and literature review. Acta Neurochir 2018; 160: 1729–1735.

Whitaker-Lea

Toms

, et al Neurologic complications in patients with left ventricular assist devices: single institution retrospective review. World Neurosurg 2020; 139: e635–e642.

H CUP-US. NIS Overview, https://hcup-us.ahrq.gov/nisoverview.jsp (2021, accessed 5 October 2021)

10.

Tirschwell

Longstreth

Jr.

Validating administrative data in stroke research. Stroke 2002; 33: 2465–2470.

11.

Hsieh

Tsai

, et al Performance of ICD-10-CM diagnosis codes for identifying acute ischemic stroke in a national health insurance claims database. Clin Epidemiol 2020; 12: 1007–1013.

12.

Lovelace

Shabaneh

De La Cruz

, et al The joint association of septicemia and cerebrovascular diseases with in-hospital mortality among patients with left ventricular assist device in the United States. J Stroke Cerebrovasc Dis 2021; 30: 105610.

13.

Briasoulis

Chehab

Alvarez

In-hospital outcomes of left ventricular assist devices (LVAD) patients undergoing noncardiac surgery. ASAIO J 2021; 67: 144–148.

14.

Baram

Daroowalla

Garcia

, et al Use of the all patient refined-diagnosis related group (APR-DRG) risk of mortality score as a severity adjustor in the medical ICU. Clin Med Circ Respirat 2008; 2: 19–25.

15.

Powers

Rabinstein

Ackerson

, et al Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50: e344–e418.

16.

Al-Mufti

Bauerschmidt

Claassen

, et al Neuroendovascular interventions for acute ischemic strokes in patients supported with left ventricular assist devices: a single-center case series and review of the literature. World Neurosurg 2016; 88: 199–204.

17.

Willey

Demmer

Takayama

, et al Cerebrovascular disease in the era of left ventricular assist devices with continuous flow: risk factors, diagnosis, and treatment. J Heart Lung Transplant 2014; 33: 878–887.

18.

Kitano

Sakaguchi

Yamagami

, et al Mechanical thrombectomy in acute ischemic stroke patients with left ventricular assist device. J Neurol Sci 2020; 418: 117142.